Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transcription regulators altered in hematologic malignancy.

J J Yunis1, J D Thompson

  • 1Department of Neoplastic Diseases Hahnemann, University Philadelphia, PA 19102.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unusual <i>5f</i> magnetism in new kagome material UV<sub>6</sub>Sn<sub>6</sub>.

npj quantum materials·2025
Same author

The impact of technical and environmental conditions on the quality assessment in mammography.

Radiography (London, England : 1995)·2024
Same author

Normal Fermi Surface in the Nodal Superconductor CeCoIn_{5} Revealed via Thermal Conductivity.

Physical review letters·2024
Same author

Absence of Spontaneous Magnetic Fields due to Time-Reversal Symmetry Breaking in Bulk Superconducting UTe_{2}.

Physical review letters·2023
Same author

Constraints on the Decay of ^{180m}Ta.

Physical review letters·2023
Same author

A scoping review of clinical practices and adherence to UK national guidance related to the placement and position confirmation of adult nasogastric feeding tubes.

Radiography (London, England : 1995)·2022
Same journal

XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

Nouvelle revue francaise d'hematologie·1995
Same journal

Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

Nouvelle revue francaise d'hematologie·1995
Same journal

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Selection and expansion of CD34+ cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995
See all related articles

Recurrent genetic rearrangements in hematologic malignancies create gene fusions. These alterations impact DNA binding transcriptional regulatory genes, offering potential as diagnostic markers for disease activity.

Area of Science:

  • Molecular biology
  • Genetics
  • Hematology

Background:

  • Hematologic malignancies frequently exhibit cytogenetic abnormalities.
  • Gene fusions resulting from rearrangements alter gene expression and activity.
  • DNA binding transcriptional regulatory genes are increasingly recognized in these alterations.

Purpose of the Study:

  • To review the impact of genetic rearrangements on transcriptional regulatory proteins.
  • To discuss the utility of these abnormalities as quantitative diagnostic markers.

Main Methods:

  • Literature review of genetic rearrangements in hematologic malignancies.
  • Analysis of molecular characterization of affected genes.
  • Evaluation of diagnostic potential of observed abnormalities.

Related Experiment Videos

Main Results:

  • Genetic rearrangements significantly alter the structure and expression of transcriptional regulatory proteins.
  • These altered proteins are linked to disease activity in hematologic malignancies.

Conclusions:

  • Understanding gene fusions in transcriptional regulatory genes is crucial for hematologic malignancy research.
  • Cytogenetic abnormalities provide a basis for developing quantitative diagnostic markers.